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Differential Activation of Mitogen-Activated Protein Kinases in
AGS Gastric Epithelial Cells by cag1 and cag2 Helicobacter
pylori1
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The aim of this study was to determine whether Helicobacter pylori activates mitogen-activated protein (MAP) kinases in gastric
epithelial cells. Infection of AGS cells with an H. pylori cag1 strain rapidly (5 min) induced a dose-dependent activation of
extracellular signal-regulated kinases (ERK), p38, and c-Jun N-terminal kinase (JNK) MAP kinases, as determined by Western
blot analysis and in vitro kinase assay. Compared with cag1 strains, cag2 clinical isolates were less potent in inducing MAP kinase,
particularly JNK and p38, activation. Isogenic inactivation of the picB region of the cag pathogenicity island resulted in a similar
loss of JNK and p38 MAP kinase activation. The specific MAP kinase inhibitors, PD98059 (25 mM; MAP kinase kinase (MEK-1)
inhibitor) and SB203580 (10 mM; p38 inhibitor), reduced H. pylori-induced IL-8 production in AGS cells by 78 and 82%,
respectively (p < 0.01 for each). Both inhibitors together completely blocked IL-8 production (p < 0.001). However, the MAP
kinase inhibitors did not prevent H. pylori-induced IkBa degradation or NF-kB activation. Thus, H. pylori rapidly activates ERK,
p38, and JNK MAP kinases in gastric epithelial cells; cag1 isolates are more potent than cag2 strains in inducing MAP kinase
phosphorylation and gene products of the cag pathogenicity island are required for maximal MAP kinase activation. p38 and
MEK-1 activity are required for H. pylori-induced IL-8 production, but do not appear to be essential for H. pylori-induced NF-kB
activation. Since MAP kinases regulate cell proliferation, differentiation, programmed death, stress, and inflammatory responses,
activation of gastric epithelial cell MAP kinases by H. pylori cag1 strains may be instrumental in inducing gastroduodenal
inflammation, ulceration, and neoplasia. The Journal of Immunology, 1999, 163: 5552–5559.
Helicobacter pylori chronically infects over half theworld’s population, but in the majority of cases, infectionresults only in asymptomatic chronic active gastritis (1).
Symptomatic gastroduodenal disease, specifically peptic ulcer-
ation or gastric neoplasia, develops in only approximately 10% of
infected individuals (2–4). The host’s immune and inflammatory
response to bacterial virulence factors is likely to play a critical
role in determining the clinical outcome of H. pylori infection (5,
6). In this study we examine the ability of H. pylori to activate
mitogen-activated protein (MAP)3 kinases, key elements in the
regulation of cellular responses to external inflammatory and pro-
liferative signals. We find that different strains of H. pylori vary in
their ability to activate MAP kinase pathways in AGS gastric ep-
ithelial cells. The differential activation of MAP kinase and other
host cellular signaling pathways is a possible mechanism for
strain-specific variations in the outcome of gastric H. pylori
infection.
MAP kinases are a family of ubiquitous, highly conserved, cell
signaling molecules (7–9). Upon activation by upstream kinases,
MAP kinases phosphorylate downstream kinases and/or media-
tors, including transcription factors. MAP kinases can be activated
by a wide variety of extracellular stimuli and transmit signals from
the cell surface to the nucleus to regulate gene expression. Key
cellular functions that are regulated at least in part by MAP kinase
signaling include cell proliferation, cell survival, and cytokine pro-
duction. Three main groups of MAP kinases have been character-
ized to date: the extracellular signal-regulated kinases (ERK), the
c-Jun N-terminal kinases (JNK), and the p38 MAP kinases (7–9).
These MAP kinase subfamilies form three parallel cascades that
can be activated simultaneously or independently. ERK MAP ki-
nases are strongly activated by growth factors and phorbol ester,
but weakly by inflammatory stimuli. In contrast, JNK and p38
MAP kinases are stimulated by inflammatory cytokines and stress
stimuli, but minimally by growth factors.
We and others have shown previously that H. pylori infection
activates IL-8 gene expression in gastric epithelial cells in vitro
and in vivo (10–16). IL-8 mRNA and protein levels are increased
in the gastric mucosa of patients with H. pylori gastritis, and im-
munohistochemical studies demonstrate increased IL-8 protein in
gastric epithelial cells from infected individuals (11, 13, 16, 17).
IL-8 is a potent neutrophil-activating chemotactic cytokine or che-
mokine. Thus, IL-8 release by infected gastric epithelial cells may
be instrumental in regulating neutrophil infiltration of the gastric
mucosa in H. pylori gastritis. H. pylori also increases IL-8 mRNA
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levels and protein production in cultured monolayers of AGS and
other gastric epithelial cell lines (10, 12, 13, 15, 18). Contact with
the bacterium initiates epithelial cell signaling events that result in
activation of the transcription factor NF-kB (10, 14, 15, 19–22).
Activated NF-kB then translocates to the nucleus where it up-
regulates IL-8 gene transcription. NF-kB activation occurs within
minutes of H. pylori infection of AGS gastric epithelial cells in
vitro, and activated NF-kB is also evident in gastric epithelial cells
from patients with H. pylori gastritis (10, 14, 15, 19, 22).
The cag pathogenicity island of H. pylori is a 40-kb region
immediately upstream to the cagA gene that encodes over 40 pu-
tative bacterial proteins (12). Based on sequence homology, cag
region gene products appear to constitute a bacterial secretion sys-
tem that may be involved in the export or surface expression of
bacterial virulence factors. In the developed world, approximately
70% of clinical H. pylori isolates carry the cag pathogenicity is-
land. Carriage of cag1 strains has been associated in most pub-
lished studies with more severe gastritis and a greater risk for
peptic ulceration and gastric cancer than H. pylori cag2 infection
(6, 12, 23–26). Gene products of the cag pathogenicity island are
also known to participate in epithelial cell activation by H. pylori.
H. pylori cag1 strains are more potent in activating epithelial cell
IL-8 production than cag2 bacteria (16, 27). Furthermore, disrup-
tion of specific cag region genes markedly reduces H. pylori-me-
diated tyrosine phosphorylation of gastric epithelial cell proteins,
NF-kB activation, and IL-8 gene transcription (12, 14, 19, 21,
22, 28).
A number of recent studies implicate MAP kinases as upstream
mediators of NF-kB activation and cytokine gene expression (9,
29–34). This led us to examine whether MAP kinases participate
in regulating H. pylori-induced IL-8 production by gastric epithe-
lial cells. The aims of this study were to determine whether H.
pylori activates MAP kinases in AGS gastric epithelial cells,
whether MAP kinase activation is required for H. pylori-mediated
NF-kB activation and IL-8 production, and whether cag1 and
cag2 strains of H. pylori differ in their ability to activate epithelial
cell MAP kinases.
Materials and Methods
AGS and MKN-28 gastric epithelial cell lines
AGS gastric epithelial cells (American Type Culture Collection, Manassas,
VA) were grown in Ham’s F-12 medium (pH 7.4; Sigma, St. Louis, MO)
supplemented with 10% FBS, 100 U/ml penicillin G sodium, and 100
mg/ml streptomycin sulfate (15). MKN-28 cells (provided by R. Peek, Jr.,
Nashville TN) were grown in DMEM with 10% FBS, 100 U/ml penicillin
G sodium, and 100 mg/ml streptomycin sulfate. All cultures were main-
tained at 37°C in a humidified atmosphere of 95% air and 5% CO2. Cell
culture experiments were conducted in 6-, 12-, or 96-well polypropylene
tissue culture plates (Corning Costar, Cambridge, MA).
H. pylori strains, clinical isolates, and isogenic mutants
H. pylori were plated onto Brucella agar supplemented with 5% horse
blood (BBL, Becton Dickinson Microbiology, Cockeysville, MD) and in-
cubated at 37°C in a microaerophilic environment (15, 35). After 3–7 days
the bacteria were harvested into pyrogen-free Dulbecco’s PBS (Cellgro,
Mediatech, Herndon,VA). The bacteria were pelleted by centrifugation at
4000 3 g for 10 min, and bacterial numbers were determined by resus-
pension in PBS to an OD600 nm of 1.5, corresponding to 3.6 3 108 CFU/ml
as described previously (15). Defined numbers of bacteria were then re-
suspended in antibiotic-free Ham’s F-12 medium. Unless otherwise stated
experiments were performed using the cagA1 and vacA1 H. pylori strain
43504 (American Type Culture Collection) (15).
H. pylori clinical strains were isolated from gastric mucosal biopsies
obtained during upper gastrointestinal endoscopy as previously described
(16). The presence of cagA was determined by PCR of bacterial genomic
DNA and vacuolating cytotoxin activity was determined by neutral red
assay (16, 36). All of the cag1 clinical isolates used in this study were
toxigenic, while the cag2 strains did not produce a functional cytotoxin.
Isogenic H. pylori mutants lacking the picB or cagA genes were also stud-
ied together with their parental cag1, toxigenic, wild-type strain (no.
60190) (28). The H. pylori clinical isolates, strain 60190, and the picB2
and cagA2 mutants were obtained from the culture collection of the
Vanderbilt University Campylobacter and Helicobacter Laboratory (Nash-
ville, TN) and have been described previously (16, 28).
H. pylori filtrate was prepared by suspending the bacteria in antibiotic-
free medium for 30 min at room temperature, pelleting the bacteria at
4000 3 g for 10 min and then filtering the medium through a 0.2-mm pore
size filter (Acrodisc, Gelman, Ann Arbor, MI). In some experiments H.
pylori were heat treated for 30 min by boiling or were treated with 2 or 20
mg/ml chloroamphenicol (Amersham, Arlington Heights, IL) for 60 min
at 37°C.
Western blot analysis of phospho-specific MAP kinase activation
AGS cells were grown to confluence on twelve-well plates and maintained
in serum-free medium for 24 h before the experiment. Cells were fed with
fresh serum-free medium 2 h before stimulation. At the end of the exper-
iment the monolayers were washed three times with PBS and lysed with
SDS buffer (containing 62.5 mM Tris-HCl (pH 6.8), 2% (w/v) SDS, 10%
glycerol, 50 mM DTT, 0.1% (w/v) bromophenol blue). Samples were then
sonicated, heated to 100°C for 5 min, and loaded onto a 10% SDS-PAGE
gel. After running the gel, the proteins were transferred onto nitrocellulose
membranes (Bio-Rad, Hercules, CA). The membranes were blocked for 3 h
at room temperature with a 5% (w/v) solution of dried milk in Tris-buffered
saline (pH 7.4). This was followed by an overnight incubation at 4°C with
the phospho-specific MAP kinase Abs diluted 1/1000 in blocking buffer.
The membranes were then washed three times with Tris-buffered saline and
incubated at room temperature for 1 h with peroxidase-conjugated goat
anti-rabbit IgG (1/2000 dilution; Jackson ImmunoResearch Laboratories,
West Grove, PA). A SuperSignal chemiluminescent substrate (Pierce,
Rockford, IL) was used for detection.
Phospho-specific p44/p42 MAP kinase Ab was used to detect ERK1/2.
This Ab detects p44 and p42 MAP kinase (ERK1 and ERK2) only when
they are catalytically activated by phosphorylation at Thr202 and Tyr204.
Phospho-specific p38 MAP kinase Ab was used to detect p38 activated by
phosphorylation at Thr180 and Tyr182. Phospho-specific p54/p46 MAP ki-
nase Ab was used to detect JNK. This Ab detects p54 and p46 MAP kinase
only when they are activated by phosphorylation at Thr183 and Tyr185. All
three Abs were obtained from New England Biolabs (Beverly, MA). Non-
phosphospecific Abs to ERK, p38, and JNK were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA). Controls for these Western blot
experiments consisted of AGS cells harvested at the zero time point for
kinetic experiments or cultured in the absence of H. pylori and harvested
at the same time as the test cells (usually after 1 h of incubation) for all
other experiments.
In vitro kinase assay
Confluent monolayers of AGS cells were lysed in 1 ml of lysis buffer (150
mmol NaCl, 1% Nonidet P-40, 0.8 mmol MgCl2, 5 mmol EGTA, 1 mmol
Na3VO4, 15 mg/ml leupeptin, 1 mmol PMSF, and 50 mmol HEPES, pH
7.5). ERK2 (p42), p38, or JNK1 (p46) MAP kinases were precipitated with
2 mg of rabbit specific IgG (Santa Cruz Biotechnology). After incubation
for 2 h at 4°C, 20 ml of protein G-Sepharose (Santa Cruz Biotechnology)
were added, and samples were further incubated for 1 h. Immunopellets
were washed twice in lysis buffer, twice in kinase buffer (30 mM NaCl, 0.1
mM Na3VO4, 2 mM DTT, 20 mM MgCl2, and 30 mmol HEPES, pH 7.5.)
and then resuspended in 40 ml of kinase buffer. The kinase reaction was
started by addition of 20 mM ATP, 100 mCi/ml [g-32P]ATP (DuPont-NEN,
Boston, MA), and 10 mg myelin basic protein (Sigma) as substrate for ERK
and p38, and 2 mg of GST c-Jun1–79 (Stratagene, La Jolla, CA) as substrate
for JNK1. Samples were subjected to SDS-PAGE (12%) and analyzed by
autoradiography.
Treatment of AGS cells with specific MAP kinase inhibitors
In some experiments AGS cells were treated with the specific p38 MAP
kinase inhibitor SB203580 (10 mM; Calbiochem, La Jolla, CA) for 30 min
before exposure to H. pylori and during the incubation period of the ex-
periment (37). A similar protocol was used for experiments using the MAP
kinase inhibitor PD98059 (25 mM; Calbiochem). PD98059 blocks ERK1/2
activation by specifically inhibiting MEK1, the kinase that catalyzes
ERK1/2 phosphorylation (38).
IL-8 protein levels in AGS cell-conditioned medium were measured by
ELISA as previously described (15, 35, 39). Statistical analyses were per-
formed using SigmaStat for Windows version 2.0 (Jandel Scientific Soft-
ware, San Rafael, CA). Unless stated otherwise, ANOVA followed by
protected t tests were used for intergroup comparisons.
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Western blot analysis of IkBa degradation
AGS cells were pretreated with the specific MAP kinase inhibitors
PD98059 (25 mM) and/or SB203580 (10 mM) for 30 min preceding in-
fection with H. pylori (108 bacteria/ml). Incubation of AGS cells with H.
pylori was maintained for 1 h in the presence of the inhibitors, after which
time the cells were washed three times with PBS and lysed. Equal amounts
of protein were loaded onto a 10% SDS-PAGE, the gel was run, and the
proteins were then transferred to nitrocellulose membranes. The blots were
blocked for 1 h in a 5% (w/v) solution of dried milk in Tris-buffered saline
solution containing 0.1% Tween-20, followed by immunoblotting with a
rabbit polyclonal Ab against IkBa (Santa Cruz Biotechnology) at a 1/1000
dilution. After washing the blot three times with Tris-buffered saline, a
peroxidase-conjugated goat anti-rabbit Ab (Jackson ImmunoResearch Lab-
oratories) at a 1/2000 dilution was applied. Immunoreactive bands of the
36-kDa IkBa protein were detected using SuperSignal chemiluminescent
substrate.
EMSA for NF-kB activation
AGS cells were pretreated for 30 min with the MAP kinase inhibitors
PD98059 (25 mM) and/or SB203580 (10 mM). The AGS monolayers were
then infected with H. pylori for 1 h. To prepare nuclear extracts AGS cells
were washed three times with ice-cold PBS and scraped in ice-cold TNE
buffer (40 mmol/L Tris-HCl (pH 7.5), 0.15 mol/L NaCl, and 1 mmol/L
EDTA). Cells were pelleted by centrifugation and then resuspended in 400
mL of buffer A (10 mmol/L HEPES (pH 7.9), 10 mmol/L KCl, 0.1 mmol/L
EDTA, 0.1 mmol/L ethylene glycol-bis(B-aminoethyl ether)-N,N,N9,N9-
tetra-acetic acid, and 0.5 mmol/L PMSF), and incubated on ice for 10 min.
Nonidet P-40 (23 ml of a 10% solution) was added, and the cells were
incubated for an additional 2 min on ice. After centrifugation at 12,000 3
g for 5 s, the nuclear pellet was resuspended in 85 ml of buffer B (20
mmol/L HEPES (pH 7.9), 0.42 mol/L KCl, 1 mmol/L EDTA, 1 mmol/L
ethylene glycol-bis(B-aminoethyl ether)-N,N,N9,N9-tetra-acetic acid, and
0.1 mmol/L PMSF) and incubated on ice for 30 min. After a further cen-
trifugation at 12,000 3 g, for 2 min, the supernatants were recovered as
nuclear extracts that were immediately frozen on dry ice and stored
at 280°C.
Single-stranded complementary oligonucleotides bearing the human
IL-8 gene NF-kB site were prepared by custom oligonucleotide synthesis
(Genosys Biotechnologies, The Woodlands, TX). After annealing, 100 ng
of the double-stranded oligonucleotide was labeled in a Klenow fill-in re-
action in the presence of [a-32P]dCTP. The probe was then purified on a
Sephadex G-25 spin column (Boehringer Mannheim, Indianapolis, IN) and
diluted to yield approximately 15,000 cpm and 0.1 ng of DNA/mL. Binding
reactions (20 ml) contained 0.1 ng (;15,000 cpm) of double-stranded
probe, 5–12 mg of extracted protein (the protein concentration of the sam-
ples were adjusted to ensure equal loading), 2 mg of poly(dI-dC) (Phar-
macia, Piscataway, NJ), 10 mmol/L 2-ME, and 1% Ficoll. After first in-
cubating the protein extracts for 10 min at room temperature, the
radiolabeled probe was added. After an additional 30 min at room temper-
ature, the reaction mixtures were then loaded on a nondenaturing 6% poly-
acrylamide gel in 0.2 mol/L glycine, 25 mmol/L Tris-HCl, and 1 mmol/L
EDTA. The gel was run, dried, and exposed to autoradiography film for
6–18 h at 280°C with an intensifying screen.
Supershift assays with anti-NF-kB p50 (sc-114), and anti-NF-kB p65
(sc-109; both from Santa Cruz Biotechnology) were performed to confirm
the identity of the complexes binding the IL-8 promoter kB probe. Each Ab
(2 mg) was added to the DNA probe at the start of the 30-min incubation.
Results
H. pylori activates MAP kinases in AGS gastric epithelial cells
Confluent monolayers of AGS gastric epithelial cells were infected
with H. pylori strain 43504 at bacterial densities ranging from
106-108/ml. After 1 h cell lysates were prepared and examined by
Western blot analysis using phospho-specific Abs to ERK1/2, p38,
and JNK isoforms p54 and p46. Control cells showed low or un-
detectable levels of activated MAP kinases (Fig. 1A). Contact with
H. pylori resulted in a marked and dose-dependent increase in the
phosphorylation of all three MAP kinases. In the case of ERK, two
immunoreactive bands are evident representing phosphorylated
p44 (ERK1, upper band) and p42 (ERK2, lower band) MAP ki-
nases. For JNK two immunoreactive bands are again evident rep-
resenting phosphorylated p54 (upper band) and p46 (lower band)
MAP kinases.
Activation of AGS cell MAP kinases by H. pylori was con-
firmed using in vitro kinase assays. As shown in Fig. 1B the kinase
activities of ERK2, p38, and JNK1 in cell extracts were each mark-
edly increased within 30 min of H. pylori inoculation of AGS
monolayers.
Intact H. pylori are required to activate MAP kinases in AGS
cells
We and others have reported that contact with intact bacteria is
required for H. pylori-mediated activation of the transcription fac-
tor NF-kB in gastric epithelial cells (10, 15, 18, 20, 21). We next
examined whether contact with H. pylori was also required for
epithelial cell MAP kinase activation. As shown in Fig. 2 H. pylori
that were killed by heat treatment for 30 min at 100°C were no
longer capable of MAP kinase induction. Soluble factors contained
in a cell-free H. pylori filtrate also failed to activate epithelial cell
MAP kinases. Pretreatment of H. pylori with chloramphenicol, a
bacteriostatic agent that inhibits bacterial protein synthesis, had no
apparent inhibitory effect on MAP kinase phosphorylation. These
data demonstrate that MAP kinase activation requires live, intact
bacteria and does not result from soluble factors present in bacte-
rial culture filtrate. However, de novo bacterial protein synthesis is
not required.
H. pylori cag1 and cag2 strains induce different patterns of
MAP kinase activation in AGS gastric epithelial cells
Fig. 3A illustrates the time course of MAP kinase activation fol-
lowing gastric epithelial cell contact with H. pylori. Phosphoryla-
tion of ERK1/2 and p38 are clearly evident within 5 min of H.
pylori inoculation. Both JNK isoforms are activated within 30 min.
Phosphorylation of ERK1/2, p38, and JNK appears to be maximal
at 30–60 min.
FIGURE 1. H. pylori activates the MAP Kinases ERK, p38, and JNK in
AGS gastric epithelial cells. A, AGS monolayers were cultured alone (Con-
trol) or with H. pylori (108-106 bacteria/ml). After 1 h cell lysates were
prepared and subjected to Western blot analyses using phospho-specific
Abs against ERK1 (p44, upper band) and ERK2 (p42, lower band), p38
and JNK p54 (upper band), and p46 (lower band) MAP kinases. B, AGS
monolayers were infected with H. pylori (108 bacteria/ml). At varying time
points cell lysates were prepared, and ERK2 (p42), p38, and JNK1 (p46)
kinase activity was measured by immunoprecipitation and in vitro kinase
assay.
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H. pylori strains that carry the cag pathogenicity island (cag1)
show greater potency in activating gastric epithelial cell inflam-
matory responses (12, 14, 16, 18, 21, 22, 27, 28, 40). Infection with
cag1 strains may also be associated with a greater risk for symp-
tomatic gastroduodenal disease (6, 12, 23–26). This led us to de-
termine whether cag1 and cag2 strains of H. pylori differ in their
ability to activate epithelial cell MAP kinases. As shown in Fig. 3A
incubation of AGS cells with the cag1 H. pylori strain 43504
resulted in marked activation of ERK1/2, p38, and JNK. Incuba-
tion with the same concentration of a cag2 H. pylori (strain J68)
again resulted in the rapid activation of ERK1/2 (Fig. 3B). How-
ever, the intensity of ERK1/2 phosphorylation was less than that
observed with the cag1 strain. The cag2 isolate also induced far
less phosphorylation of p38 and very little phosphorylation of JNK
compared with the cag1 strain.
The differences in MAP kinase activation induced by strains
43504 and J68 led us to study a panel of cag1 and cag2 H. pylori
clinical isolates. As illustrated in Fig. 4 all three of the cag1 H.
pylori isolates induced a marked activation of the MAP kinases
ERK1/2, p38 and JNK. Each of the three cag2 H. pylori isolates
was less potent in inducing MAP kinase activation. Furthermore, a
consistent pattern of differential MAP kinase phosphorylation was
observed with the three cag2 strains; ERK1/2 phosphorylation
was somewhat less intense than with the cag1 strains, p38 phos-
phorylation was substantially less, and there was minimal phos-
phorylation of JNK.
The product of the picB region of the cag pathogenicity island
of H. pylori participates in MAP kinase activation in AGS
gastric epithelial cells
Having found distinct patterns of MAP kinase activation by cag1
and cag2 H. pylori clinical isolates, we next examined the partic-
ipation of specific cag pathogenicity island gene products in this
process. The picB region of the cag pathogenicity island is known
to be involved in gastric epithelial cell NF-kB activation and IL-8
up-regulation (12, 14, 22, 28). As shown in Fig. 5 the cag1 ref-
erence strain 60190 (wild type) induced the phosphorylation of
ERK1/2, p38, and JNK in AGS gastric epithelial cells as observed
with other cag1 H. pylori. The cagA2 isogenic mutant was similar
to the wild type in terms of its ability to activate epithelial cell
MAP kinases apart from a possible reduction in ERK1/2 phos-
phorylation. However, the picB2 isogenic mutant was less potent
in inducing epithelial cell MAP kinase activation. Compared with
the parental wild-type strain, ERK1/2 phosphorylation was only
slightly reduced, p38 phosphorylation was moderately reduced,
and JNK phosphorylation was markedly reduced. Thus, disruption
of picB in this cag1 strain resulted in a pattern of MAP kinase
activation similar to that seen with cag2 strains (see Fig. 4).
MAP kinase activation is required for IL-8 up-regulation in H.
pylori-infected AGS gastric epithelial cells
H. pylori infection is known to stimulate gastric epithelial cell IL-8
production, and MAP kinases have been reported to regulate the
upstream signaling events that control cytokine transcription. We
asked, therefore, whether MAP kinase activation might be in-
volved in H. pylori-induced IL-8 production by gastric epithelial
cells. In these experiments we used the specific MAP kinase in-
hibitors SB203580, which blocks p38 kinase activity, and
PD98059, which blocks MEK1 kinase activity, thereby preventing
ERK1/2 phosphorylation. In control experiments, SB203580 (10
mM) inhibited p38 MAP kinase activity in H. pylori-infected
(strain 43504; 108 bacteria/ml) AGS cells as demonstrated using
the in vitro p38 kinase assay (data not shown). Similarly, the abil-
ity of PD98059 (25 mM) to block MEK1 kinase activity in H.
pylori-infected AGS cells was confirmed by Western blotting us-
ing the phosphospecific ERK1/2 Ab (data not shown).
AGS cells were pretreated for 30 min with the MAP kinase
inhibitors used singly or in combination. The gastric epithelial cell
monolayers were then inoculated with H. pylori (strain 43504; 108
FIGURE 2. Contact with intact bacteria is required for H. pylori-medi-
ated MAP kinase activation in gastric epithelial cells. AGS monolayers
were incubated alone (Control) or with live H. pylori (108 bacterial/ml),
heat-killed H. pylori (100°C for 30 min), a sterile H. pylori filtrate, or
bacteria that had been pretreated for 60 min with chloramphenicol (2 or 20
mg/ml). Epithelial cell lysates were prepared after 1 h of incubation and
analyzed by Western blot using phospho-specific MAP kinase Abs. These
experiments were performed on three occasions, and a representative blot
is shown.
FIGURE 3. cag1 and cag2 H. pylori strains differ
in their ability to activate MAP kinases. A, AGS
monolayers were infected with H. pylori cag1 strain
43504 (108 bacteria/ml). Cell lysates were prepared
after varying incubation times and subjected to West-
ern blot analyses using phospho-specific MAP kinase
Abs. B, AGS monolayers were infected with H. pylori
cag2 strain J68 (108 bacteria/ml). Cell lysates were
prepared after varying incubation times and subjected
to Western blot analyses using phospho-specific MAP
kinase Abs. These experiments were performed on
three occasions, and representative blots are shown.
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bacteria/ml). IL-8 levels were measured in the conditioned me-
dium harvested 7 h later.
H. pylori induced a 36-fold increase in AGS cell IL-8 produc-
tion (Fig. 6). The p38 inhibitor SB303580 reduced epithelial cell
IL-8 production by 82% ( p , 0.001), the MEK1 inhibitor
PD98059 reduced IL-8 production by 78% ( p , 0.001), and a
combination of the two inhibitors completely abrogated H. pylori
stimulation of IL-8 production (42% of control IL-8 level; p ,
0.0001).
Using the MKN-28 gastric epithelial cell line, the p38 inhibitor
reduced H. pylori-stimulated IL-8 production by 39% (from 251 6
7 to 152 6 5 pg/ml, mean 6 SD; n 5 4; p , 0.001), the MEK1
inhibitor by 60% (from 251 6 7 to 100 6 14 pg/ml; n 5 4; p ,
0.001), and a combination of the two inhibitors by 100% (from
251 6 7 to 0 6 8 pg/ml; n 5 4; p , 0.001).
IkBa degradation and NF-kB activation are not altered by the
MAP kinase inhibitors PD98059 and SB203580 in H. pylori-
infected AGS gastric epithelial cells
Previous studies have demonstrated that cag1 H. pylori activate
gastric epithelial cell NF-kB, leading to up-regulation of IL-8
mRNA transcription and protein production (12, 14, 15, 22, 28).
We now find that cag1 bacteria also activate MAP kinases, leading
to an increase in IL-8 production by gastric epithelial cell lines. In
view of these parallel findings we next asked whether MAP kinase
activation was part of the upstream signaling pathway leading to
IkB kinase activation, IkB degradation, and the subsequent acti-
vation and nuclear translocation of NF-kB.
As shown in Fig. 7A detectable levels of IkBa were evident in
control AGS gastric epithelial cells by Western blot analysis. Ex-
posure of the gastric epithelial cell to H. pylori resulted in a
marked reduction in IkBa levels consistent with IkBa kinase ac-
tivation leading to IkBa phosphorylation and degradation. This
marked reduction in IkBa levels was not prevented by pretreat-
ment of epithelial cells with the MAP kinase inhibitors PD98059
and/or SB203580.
Fig. 7B shows an EMSA of nuclear extracts from AGS gastric
epithelial cells examining NF-kB binding to an oligonucleotide
probe containing the IL-8 promoter kB binding sequence. Nuclear
extracts from control cells contained little activated NF-kB (lane
FIGURE 4. cag1 and cag2 H. pylori strains
demonstrate a consistent pattern of differential
MAP kinase activation. AGS monolayers were
cultured alone (Control) or were infected with one
of three H. pylori cag1 strains (108 bacteria/ml;
lane 2, J166; lane 3, J238; lane 4, 43504) or with
one of three H. pylori cag2 clinical isolates (108
bacteria/ml; lane 6, J68; lane 7, J44; lane 8, J190).
After 1 h of incubation, cell lysates were prepared
and then subjected to Western blot analyses using
phospho-specific MAP kinase Abs (upper panels).
Western blots performed using control Abs that
recognize ERK, p38, or JNK regardless of their
phosphorylation states are shown (lower panels).
These experiments were performed on three occa-
sions, and a representative blot is shown.
FIGURE 5. The picB region of the cag pathogenicity island participates
in MAP kinase activation. AGS monolayers were cultured alone (Control)
or were infected with the H. pylori cag1 strain 60190 (wild type; 108
bacteria/ml), or with isogenic mutants lacking the cag pathogenicity island
genes picB (picB2) or cagA (cagA2). After 1 h of incubation cell lysates
were prepared and then subjected to Western blot analyses using phospho-
specific MAP kinase Abs. These experiments were performed on three
occasions, and a representative blot is shown.
FIGURE 6. MAP kinase activation is required for IL-8 up-regulation in
H. pylori-infected AGS gastric epithelial cells. AGS monolayers were cul-
tured alone (Control) or were infected with the H. pylori cag1 strain 43504
(108 bacteria/ml) with or without pretreatment with the p38 inhibitor
SB203580 (10 mM) and/or the MEK1 inhibitor PD98059 (25 mM). IL-8
levels were measured in conditioned medium harvested after 7 h. Data are
expressed as the mean 6 SD (n 5 4).
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1). NF-kB binding to the IL-8 promoter site was markedly in-
creased following H. pylori infection (lane 2). Activation and nu-
clear translocation of NF-kB did not appear to be influenced by the
MAP kinase inhibitors PD98059 and/or SB203580 (lanes 3–5).
EMSA supershift studies using Abs to p50 and p65 kB proteins
confirmed that p65-containing NF-kB is the predominant form
binding to the IL-8 promoter site.
Discussion
We have shown that contact with H. pylori rapidly activates
ERK1, ERK2, p38, JNK p46, and JNK p54 MAP kinases in AGS
gastric epithelial cells. We also find that H. pylori cag1 strains are
more potent than cag2 strains in inducing MAP kinase activation.
Differential MAP kinase activation by cag1 and cag2 H. pylori
strains is particularly evident for JNK phosphorylation and appears
to be dependent upon genes within the cag pathogenicity island.
Inhibitors of p38 and MEK1 MAP kinases prevent H. pylori-in-
duced IL-8 production. However, p38 and MEK1 MAP kinase
activity do not appear to be essential for H. pylori-induced NF-kB
activation.
H. pylori has adapted to interact specifically with gastric-type
epithelial cells. H. pylori infection is limited to areas of the gas-
trointestinal tract that are lined by gastric epithelium, and the bac-
terium is known to activate several gastric epithelial cell signaling
events. Previous studies have shown that adherence of H. pylori to
AGS gastric epithelial cells induces tyrosine phosphorylation of
host proteins, cytoskeletal reorganization, NF-kB activation, and
up-regulation of expression of a variety of inflammatory response
genes including IL-8 (10, 13, 15, 21, 41). We now report that H.
pylori also induces the phosphorylation of ERK, JNK, and p38
MAP kinase family members. Threonine and tyrosine phosphory-
lation of MAP kinases was evident within 5 min of H. pylori in-
oculation. Contact with intact bacteria appears to be required for
MAP kinase activation. A similar requirement for bacterial contact
or adherence was described previously for gastric epithelial cell
NF-kB activation by H. pylori (15). Our experiments using the
bacterial protein synthesis inhibitor chloramphenicol indicate that
MAP kinase activation does not require de novo bacterial protein
production. Instead, epithelial cell activation appears to result from
contact with preformed bacterial factors, which is consistent with
the observed rapid onset of MAP kinase activation.
We did not examine specifically whether H. pylori LPS activates
MAP kinases in AGS cells. However, in a previous study we were
unable to demonstrate AGS cell NF-kB activation (or IL-8 pro-
duction) in response to LPS (15). Furthermore, soluble factors
present in bacterial culture filtrate did not activate AGS cell MAP
kinases. These findings suggest that H. pylori LPS is not respon-
sible for MAP kinase activation in gastric epithelial cells. This is
in contrast to human monocytic cells, which are activated by H.
pylori culture filtrate and by purified H. pylori LPS as shown by
other investigators and by us (35, 42–44).
We find that H. pylori cag1 strains are more potent than cag2
strains in inducing gastric epithelial cell MAP kinase phosphory-
lation. A consistent pattern of differential MAP kinase activation
was observed with the panel of cag1 and cag2 isolates examined
in this study. The most striking differences between the cag1 and
cag2 strains were seen for JNK phosphorylation, which was min-
imal after exposure to the cag2 bacteria. p38 MAP kinase activa-
tion was also far less evident with the cag2 strains. In previous
studies, disruption of the picB region of the cag pathogenicity is-
land resulted in a marked reduction in the ability of H. pylori to
activate epithelial cell NF-kB and up-regulate IL-8 protein pro-
duction (22, 28). We now find that a picB2 mutant also shows
reduced potency in MAP kinase activation compared with its cag1
parental strain. Again, an almost complete loss of JNK activation
and a markedly reduced potency of p38 activation were evident.
Thus, the pattern of MAP kinase activation induced by the picB2
mutant recapitulates the pattern observed using the cag2 clinical
isolates. These findings indicate that gene products of the cag
pathogenicity island are necessary for the observed differences in
MAP kinase induction by H. pylori cag1 and cag2 strains.
H. pylori vacuolating cytotoxin has been reported to inhibit
EGF-mediated signal transduction and ERK2 activation in Kato III
gastric epithelial cells (45, 46). Broth culture supernatants from a
vacA1 H. pylori strain, but not its isogenic vacA2 mutant, inhib-
ited epithelial cell EGF receptor activation, and ERK2 phosphor-
ylation in response to EGF. We now find that H. pylori bacteria,
but not culture filtrate, activate ERK1 and ERK2 in gastric epi-
thelial cells. Furthermore, ERK activation is more pronounced fol-
lowing exposure to cag1 strains compared with cag2 strains that
secrete less vacuolating cytotoxin. Thus, vacuolating cytotoxin
produced by cag1 bacterial strains in our experimental system is
unable to prevent H. pylori-induced ERK activation. The interplay
between bacterial activation of gastric epithelial cell MAP kinases
and the blockade of related signaling pathways by vacuolating cy-
totoxin requires further investigation.
MAP kinase signaling regulates the expression of many proin-
flammatory cytokines, including IL-8. This led to our experiments
using the specific MAP kinase inhibitors SB203580, which blocks
p38 kinase activity, and PD98059, which blocks MEK1 activity,
thereby preventing ERK1/2 phosphorylation. Unfortunately, a
suitable JNK inhibitor was not available for use in our studies.
Both SB203580 and PD98059 substantially reduced IL-8 produc-
tion by H. pylori-stimulated AGS cells. Thus, activation of both
the p38 and MEK1-ERK1/2 pathways are required for a maximal
gastric epithelial cell IL-8 response to H. pylori. When both path-
ways were blocked by combining the two inhibitors, H. pylori-
induced IL-8 production was abolished.
FIGURE 7. The MAP kinase inhibitors PD98059 and SB203580 do not
influence IkBa degradation and NF-kB activation in H. pylori-infected
AGS gastric epithelial cells. AGS monolayers were cultured alone (Con-
trol) or were infected with the H. pylori cag1 strain 43504 (108 bacteria/
ml) with or without 30 min of pretreatment with the p38 inhibitor
SB203580 (10 mM) and/or the MEK1 inhibitor PD98059 (25 mM). A,
After 1 h cell lysates were prepared and subjected to Western blot analysis
for evaluation of IkBa levels. B, Nuclear extracts were also prepared (at
1 h) and evaluated by EMSA for binding activity to an IL-8-specific NF-kB
oligonucleotide probe. EMSA supershift studies were performed using Abs
against p50 and p65 NF-kB proteins. These experiments were performed
on two occasions with identical results.
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Cross-talk between the MAP kinase and NF-kB pathways has
been demonstrated in a number of recent studies. For example, the
MAP kinase family members MAP kinase kinase kinase
(MEKK1) and NF-kB-inducing kinase (NIK) can each directly
activate the IkB kinase signalsome, resulting in IkB phosphoryla-
tion and release of activated NF-kB (29–31, 47–49). Thus, we
examined whether MAP kinase activation by H. pylori was an
upstream signaling event in the pathway leading to NF-kB acti-
vation and, hence, IL-8 gene transcription. Although the MAP ki-
nase inhibitors SB203580 and PD98059 were both effective in
blocking IL-8 production, neither had any apparent effect on H.
pylori-induced IkBa degradation or on NF-kB activation and
binding to the IL-8 promoter kB site. These data suggest that p38
and MEK1 MAP kinases are not required for H. pylori-mediated
IkBa degradation or NF-kB activation. Thus, the MAP kinase and
NF-kB pathways may exert independent regulatory effects on gas-
tric epithelial cell IL-8 production following H. pylori infection. In
other systems, p38 MAP kinases and NF-kB have been shown to
regulate cytokine gene expression by independent pathways (32,
50, 51). However, the mechanism by which p38 regulates cytokine
production without altering NF-kB activation and DNA binding is
not known.
Bacterial adherence to or at least contact with the gastric epi-
thelial cell appears to be necessary for H. pylori-induced MAP
kinase activation. However, the adhesins or other bacterial factors,
host receptors, and intermediary host signaling molecules that are
engaged to activate MAP kinase family members are unknown.
Further studies are needed to elucidation these upstream events
and define the specific bacterial and host factors that interact to
activate the epithelial cell signaling pathways. The potential down-
stream effects of epithelial cell MAP kinase activation are multiple
and varied. In this study we examined MAP kinase-mediated ac-
tivation of IL-8 production. MAP kinases regulate cell prolifera-
tion, differentiation, and programmed death, in addition to stress
and inflammatory responses. Hence, activation of gastric epithelial
cell MAP kinases by H. pylori may be instrumental in inducing
gastroduodenal inflammation, ulceration, and neoplasia. The dif-
ferential activation of MAP kinases by cag1 and cag2 strains may
be an important determinant of strain-specific differences in the
host response to H. pylori infection of the gastric mucosa.
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